Skip to content

Home
About
Products & Services
Quality & Compliance
News & Events
Contact

Home
About
Products & Services
Quality & Compliance
News & Events
Contact

Awaiting product image

Home / Formulation / Biological Drug Product / mAb Formulation / Dupilumab biosimilar

Biological Drug Product, Formulation, mAb Formulation

Dupilumab biosimilar

Categories: Biological Drug Product, Formulation, mAb Formulation

Description

• Phase 1 clinical trial to begin in 2024

Related products

Formulation
tocilizumab biosimilar

Approved by US FDA
Formulation
Sevoflurane Inhalation
Formulation
Recombinant Teriparatide for Injection
Formulation
Eptifibatide Injection

Home
About
Products & Services
Quality & Compliance
News & Events
Contact

SHANDONG ZHIYE

Copyright © 2025-present zhiyesdcom. All Rights Reserved.

Added to cart

Your Cart Is Empty

0

Check out our shop to see what's available

Cart Total: Total$0.00

Your cart is empty. Shop now →

Scroll to Top